ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed

Ben Che

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5085380592. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Co-author DOI 10.1038/s41388-023-02843-y ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rongfa Yuan · 1 shared paper, 2023 · strength 0.15
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y ↗
Leifeng Chen · 1 shared paper, 2023 · strength 0.15
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y ↗
Yunyan Du · 1 shared paper, 2023 · strength 0.15
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y ↗
Wenming Zhang · 1 shared paper, 2023 · strength 0.15
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y ↗
Xueqiang Deng · 1 shared paper, 2023 · strength 0.15
- Paper SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. DOI 10.1038/s41388-023-02843-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.